We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
50 hedge funds and large institutions have $38.1M invested in Regulus Therapeutics in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
2% more funds holding
Funds holding: 49 → 50 (+1)
0.02% less ownership
Funds ownership: 0.45% → 0.43% (-0.02%)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
34% less capital invested
Capital invested by funds: $58.1M → $38.1M (-$20M)
Holders
50
Holders Change
+1
Holders Change %
+2.04%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
9
Reduced
12
Closed
9
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$8K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$361K |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$228K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$189K |
| 4 |
VF
Virtu Financial
New York
|
+$87.6K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$41.3K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$1.57M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$558K |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$449K |
| 4 |
LCM
Laurion Capital Management
New York
|
-$408K |
| 5 |
Millennium Management
New York
|
-$351K |
